In summary, our results describe a model to underpin molecular hypotheses of how Arg177 and Asp159 in the C-terminal domain of the dog PrP slow down the LLPS of PrPC and inhibit amyloid formation of PrP implicated in prion disease resistance in dogs (Fig. 8). The gene discussed is PRNP; the disease is prion disease.